Tag: New York
J&J Acquires Intra-Cellular Therapies for $14.6B, Expanding Mental Health Drug Portfolio
J&J Acquires Intra-Cellular Therapies for $14.6B, Expanding Mental Health Drug Portfolio In a groundbreaking move that has sent shockwaves through the pharmaceutical industry, Johnson & Johnson announced on Monday that it would be acquiring Intra-Cellular...
Analyzing RFK Jr.’s Financials: Biotech Investments, Health Care Consulting, and Author Introductions
Robert F. Kennedy Jr.'s Financial Disclosures Unveiled: A Closer Look at Investments and Income Sources Financial disclosures have shed light on the investment portfolio and income streams of prospective health secretary Robert F. Kennedy Jr....
Aletha Maybank Resigns as AMA’s Chief Health Equity Officer: What’s Next?
Aletha Maybank, the American Medical Association’s first chief equity officer, has announced her resignation after leading the organization for five and a half years. Maybank's departure marks a significant moment in the healthcare equity...
Pfizer Terminates Gene Therapy Deal with Sangamo: Implications for Hemophilia
Pfizer Terminates Gene Therapy Deal with Sangamo: Implications for Hemophilia In a surprising move, Pfizer has decided to halt the development of a hemophilia A gene therapy that it had licensed from Sangamo Therapeutics. This...
